Products for Research Use Only
RegisterLogin

D-threo-PDMP

CAT: 0804-HY-116392E-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-116392E-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
D-threo-PDMP is a potent glucoceramide synthase (GCS) inhibitor, which reduces the glycosphingolipids (such as GM3 and GD3) on the cell surface by inhibiting glycosylation, reduces the total length of the axon plexus and the number of axon branch points, and inhibits neurite growth. D-threo-PDMP inhibits the synthesis of GM3, thereby reducing the adhesion ability of B16 melanoma cells and mimicking the pathological effects of hyperglycemia/TGF-β1. D-threo-PDMP inhibits the synthesis of GD3, thereby protecting liver cells from apoptosis induced by TNF-α. D-threo-PDMP can be used to study diseases related to targeted glycosphingolipid metabolism[1][2][3][4].
CAS Number
109836-82-0
UNSPSC
12352005
Target
Apoptosis; Glucosylceramide Synthase (GCS)
Type
Reference compound
Related Pathways
Apoptosis; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/d-threo-pdmp.html
Purity
99.50
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
CCCCCCCCCC(N[C@H](CN1CCOCC1)[C@H](O)C2=CC=CC=C2)=O
Molecular Formula
C23H38N2O3
Molecular Weight
390.56
References & Citations
[1]Carmen García-Ruiz, et al. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest. 2003 Jan;111 (2) :197-208. |[2]Dong Hoon Kwak, et al. Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells. Life Sci. 2005 Sep 30;77 (20) :2540-51. |[3]Inokuchi J, et al. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells. J Cell Physiol. 1989 Dec;141 (3) :573-83. |[4]Hiranita T, et al. Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats. J Pharmacol Exp Ther. 2013 Oct;347 (1) :20-9.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-116392A-01(−) -L-threo-PDMP (hydrochloride)
HY-116392B-01DL-threo-PDMP (hydrochloride)
HY-116392GD, L-erythro-PDMP
HY-116392H-01D, L-erythro-PDMP (hydrochloride)
HY-116392D-01PDMP (hydrochloride)
HY-116535CD-threo-PPMP
HY-W127527-01D-threo-Dihydrosphingosine
HY-169486-01D-threo-Biopterin
HY-165761D-Threo-sphingosine
HY-116535-01D-threo-PPMP (hydrochloride)

Alternative Products

CatalogName
sc-280659D-threo-PDMP
GTR19191479(+) -D-threo-PDMP (hydrochloride)
MBS5798418(+)-D-threo-PDMP (hydrochloride)
TRC-P217390-25MGDL-threo-PDMP
JEA83681-01L-Threo-PDMP
MBS5796784(-)-L-threo-PDMP (hydrochloride)
sc-203030DL-threo-PDMP, Hydrochloride
T38080-01DL-threo-PDMP (hydrochloride)
GTR19192130(-) -L-threo-PDMP (hydrochloride)
T38489D, L-erythro-PDMP

Popular Products